Effect of chaturajata taila inhaler in allergic rhinitis

To develope and evaluate the efficacy of chaturajata taila inhaler in vataj pratishay with special reference to allergic rhinitis-a randomized controlled prospective clinical study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054256

Enrollment

100

Registered

2023-06-21

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J399- Disease of upper respiratory tract, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient having symptoms of Vataj Pratishyay Age between 18-40yrs Those who give consent as per requirement

Exclusion criteria

Exclusion criteria: Patients with known case of hypertension, Diabetic mellitus, heart disease and bronchial asthma Patients presenting with complications of pratishyay like nasal polyps, tumour of nose, DNS, old fracture of nose. If patients is suspected of COVID â?? 19 infection after scanning with respect to clinical signs & symptoms and history of patients, than he/she will be referred through proper channel for further treatment. She/he will not be included in trial

Design outcomes

Primary

Measure	Time frame
The patient will improve in nasasrav kshavathu shirashoolaTimepoint: Day 8 Day 15	—

Secondary

Measure	Time frame
The patient will improve in nasaanahaTimepoint: Day 8 Day 15	—

Countries

India

Contacts

Public ContactDr Prashant Jain

Parul institute of ayurved

pjprashantrock2@gmail.com8982530124

Outcome results